Search results for " trials"

showing 10 items of 932 documents

An evidence based therapeutic approach to hereditary and acquired angioedema

2014

Purpose of review Hereditary angioedema (HAE) due to C1 esterase inhibitor (C1-INH) deficiency (HAE-C1-INH), HAE with normal C1-INH, and acquired angioedema due to C1-INH deficiency are rare but important diseases that can be associated with significant morbidity and mortality. Research into the pathogenesis of angioedema has expanded greatly and has led to new clinical trials with novel therapeutic agents and strategies. Recent findings Strategies for managing HAE-C1-INH are aimed at treating acute attacks or preventing attacks through the use of prophylactic treatment. Agents available in Europe for treating acute attacks include plasma-derived C1-INH concentrates, a bradykinin B2 recepto…

Evidence-based practiceImmunologyBradykininBioinformaticsPathogenesischemistry.chemical_compoundTherapeutic approachBradykinin B2 Receptor AntagonistsHumansImmunology and AllergyMedicineheterocyclic compoundsRandomized Controlled Trials as TopicEvidence-Based MedicineAngioedemabusiness.industryAngioedemas HereditaryAntagonistbiochemical phenomena metabolism and nutritionrespiratory systembacterial infections and mycosesmedicine.diseaserespiratory tract diseasesClinical trialchemistryHereditary angioedemaKallikreinsmedicine.symptombusinessComplement C1 Inhibitor ProteinCurrent Opinion in Allergy & Clinical Immunology
researchProduct

Report on Italy

2019

The right to take part personally in criminal proceedings, although not expressly provided at a Constitutional level, is an expression of the principle of a fair trial upheld by Article 6 of the ECHR and translated into Article 111 of the Italian Constitution. In the course of years, the CCP, also following some condemnations by the Strasbourg Court, underwent several modifications aimed at implementing principles and conditions affirmed by the ECHR that can legitimate proceedings in absentia of a defendant. This study is structured into different parts. In the first, an analysis of national rules concerning the participation of a defendant and other private parties at each stage of proceed…

Expression (architecture)Fair trialConstitutionLawPolitical sciencemedia_common.quotation_subjectSettore IUS/16 - Diritto Processuale Penalemedia_commonParticipatory rights private parties videoconferences in absentia trials remedies letters rogatory EAW EIO.
researchProduct

The role of red yeast rice (RYR) supplementation in plasma cholesterol control: A review and expert opinion.

2019

1. Preamble : Hypercholesterolemia is a major risk factor for atherosclerotic cardiovascular disease (ASCVD) [1]. Increased levels of low density lipoprotein cholesterol (LDL-C) are associated with an increased risk of coronary heart disease (CHD) and many clinical trials have shown that reducing LDL-C levels significantly reduced the CHD and CVD risk [[2], [3], [4], [5]]. Thus LDL-C-lowering is the main approach for the management of cardiovascular disease. Current guidelines suggest LDL-C levels targets based on the individual CV risk; such targets can be achieved by several means, which include both lifestyle changes and pharmacological approaches [6], with statins being the cornerstone …

Gastrointestinal Diseases[SDV]Life Sciences [q-bio]Hypercholesterolemia/Self Medication030204 cardiovascular system & hematologyPharmacology03 medical and health sciencesFood-Drug Interactions0302 clinical medicinePlasma cholesterolBiotransformationDouble-Blind MethodChinese traditionalInternal MedicineRed yeast riceMedicineCytochrome P-450 CYP3AHumansMulticenter Studies as TopicProdrugs030212 general & internal medicineLovastatinMusculoskeletal DiseasesMedicine Chinese TraditionalExpert TestimonyComputingMilieux_MISCELLANEOUSBiotransformationRandomized Controlled Trials as TopicBiological ProductsClinical Trials as TopicMolecular StructureRyanodine receptorbusiness.industryGeneral Medicine3. Good healthCholesterol blood[SDV] Life Sciences [q-bio]CholesterolCardiovascular DiseasesExpert opinionDietary Supplementslipids (amino acids peptides and proteins)Hydroxymethylglutaryl-CoA Reductase InhibitorsCardiology and Cardiovascular Medicinebusiness
researchProduct

Gamma-secretase modulation with Abeta42-lowering nonsteroidal anti-inflammatory drugs and derived compounds.

2006

The amyloid-beta (Abeta) peptides and specifically the highly amyloidogenic isoform Abeta42 appear to be key agents in the pathogenesis of familial and sporadic forms of Alzheimer's disease (AD). The final step in the generation of Abeta from the amyloid precursor protein is catalyzed by the multiprotein complex gamma-secretase, which constitutes a prime drug target for prevention and therapy of the disease. However, highly potent gamma-secretase inhibitors that block formation of all Abeta peptides have provoked troubling side effects in preclinical animal models of AD. This toxicity can be readily explained by the promiscuous substrate specificity of gamma-secretase and its essential role…

Gene isoformendocrine systemClinical Trials as TopicNonsteroidalAmyloid beta-Peptidesmedicine.drug_classAnti-Inflammatory Agents Non-SteroidalPharmacologyIbuprofenAmyloid β peptideAnti-inflammatoryPathogenesischemistry.chemical_compoundNeurologychemistryAlzheimer DiseasemedicineAnimalsHumansNeurology (clinical)γ secretaseAmyloid Precursor Protein SecretasesGamma secretasemedicine.drugNeuro-degenerative diseases
researchProduct

Reducing treatment duration in patients infected with hepatitis C genotype 1: any need for further studies?

2009

The recommended treatment duration with pegylated interferon-α plus ribavirin for patients infected with hepatitis C virus (HCV) genotype 1 is 48 weeks. Interestingly, a subpopulation of genotype 1 patients experience rapid decreases in HCV RNA levels once treatment is initiated and attain rapid virological response, defined as undetectable HCV RNA at week 4 of therapy. Several studies have shown that these patients can be effectively treated for a 24-week period without any significant decreases in sustained virological response rates. The aim of this review was to consider the existing clinical evidence regarding the use of a 24-week treatment schedule among genotype 1 patients and to hi…

GenotypeTreatment durationHepatitis C virusHepacivirusInterferon alpha-2medicine.disease_causeAntiviral AgentsDrug Administration SchedulePolyethylene Glycolschemistry.chemical_compoundPegylated interferonGenotypeRibavirinMedicineHumansPharmacology (medical)In patientPharmacologyClinical Trials as Topicbusiness.industryRibavirinInterferon-alphaHepatitis CHepatitis C Chronicmedicine.diseaseVirologyRecombinant ProteinsInfectious DiseasesTreatment OutcomechemistryHCVDrug Therapy Combinationbusinessmedicine.drugAntiviral therapy
researchProduct

Multidisciplinary management of Hunter syndrome.

2009

Hunter syndrome is a rare, X-linked disorder caused by a deficiency of the lysosomal enzyme iduronate-2-sulfatase. In the absence of sufficient enzyme activity, glycosaminoglycans accumulate in the lysosomes of many tissues and organs and contribute to the multisystem, progressive pathologies seen in Hunter syndrome. The nervous, cardiovascular, respiratory, and musculoskeletal systems can be involved in individuals with Hunter syndrome. Although the management of some clinical problems associated with the disease may seem routine, the management is typically complex and requires the physician to be aware of the special issues surrounding the patient with Hunter syndrome, and a multidiscipl…

GerontologyAdultMalemedicine.medical_specialtyAdolescentGenotypeIdursulfaseDiseaseIduronate SulfataseYoung AdultInternal medicineAnesthesiologymedicineHumansEnzyme Replacement TherapyCooperative BehaviorIntensive care medicineChildInfusions IntravenousMucopolysaccharidosis IIRandomized Controlled Trials as TopicPatient Care Teambusiness.industryHematopoietic Stem Cell TransplantationInfant NewbornInfantHunter syndromeEnzyme replacement therapymedicine.diseaseCombined Modality TherapyRecombinant ProteinsPulmonologyPhenotypeOtorhinolaryngologyChild PreschoolPediatrics Perinatology and Child HealthInterdisciplinary CommunicationNeurosurgerybusinessmedicine.drugPediatrics
researchProduct

Promoting influenza prevention for elderly people in Hong Kong using health action process approach: study protocol.

2018

People 65 years or older are at greater risk of serious complications from the seasonal influenza compared with young. To promote elderly people’s behavioral compliance toward influenza prevention, the aim of the current project is to develop, implement, and evaluate a theory-based low-administration-cost intervention building on a leading psychological theory, the Health Action Process Approach (HAPA). The target group is Hong Kong Chinese elderly people aged 65 or older who rarely or never adopt any preventive actions. This project will be conducted in three phases over 24 months. In phase 1, intervention program will be developed building on the HAPA theoretical framework which comprises…

GerontologyAgingand promotion of well-beinglaw.inventionStudy Protocol0302 clinical medicineinfluenssaRandomized controlled trial7.1 Individual care needslawMedicine030212 general & internal medicinelcsh:Public aspects of medicineInfectious DiseasesOlder adultsPneumonia & InfluenzaPublic Health and Health ServicesHong KongPsychological theoryPublic Health0305 other medical scienceikääntyneetBehavior maintenanceHumanmedicine.medical_specialtyterveyspsykologiaClinical Trials and Supportive ActivitiesHealth Promotion03 medical and health sciencesClinical ResearchIntervention (counseling)Influenza HumanInfluenza preventionBehavioral and Social ScienceHumansAgedGovernment030505 public healthbusiness.industryHealth action process approachPublic healthPreventionPublic Health Environmental and Occupational Healthlcsh:RA1-1270Prevention of disease and conditionsInfluenzaTelephoneBehavior initiationClinical trialInfluenza preventionEmerging Infectious DiseasesGood Health and Well Beingterveyskäyttäytyminen3.1 Primary prevention interventions to modify behaviours or promote wellbeingBiostatisticsbusiness3.1 Primary prevention interventions to modify behaviours or promote well-beingProgram Evaluation
researchProduct

Is physical activity a cause of longevity? It is not as straightforward as some would believe. A critical analysis

2018

There are discrepant findings between (A) observational follow-ups and (B) interventional studies that investigate possible causal association between high physical activity and low mortality. Participation in vigorous physical activity at a specific time-point is an indicator of good fitness and health, and is associated with a reduced risk of death. However, neither randomised controlled trials nor experimental animal studies have provided conclusive evidence to show that physical activity started during adulthood extends lifespan. Consequently, the undisputed health-related benefits of exercise have yet to translate into any proven causal relationship with longevity. Physical activity im…

GerontologyHealth Statusmedia_common.quotation_subjectLongevitySpecific timePhysical activityPhysical Therapy Sports Therapy and Rehabilitation030204 cardiovascular system & hematologyPhysical function03 medical and health sciences0302 clinical medicineAnimalsHumansMedicineOrthopedics and Sports Medicine030212 general & internal medicineElderly adultsExerciseRandomized Controlled Trials as Topicmedia_commonbusiness.industryLongevityGeneral MedicineObservational Studies as TopicExperimental animalPhysical FitnessCausal associationObservational studybusinessBritish Journal of Sports Medicine
researchProduct

Special Issue "Centenarians-A Model to Study the Molecular Basis of Lifespan and Healthspan".

2021

People are living longer, not, as was previously the case, due to reduced child mortality, but because we are postponing the ill-health of old age [...]

GerontologyLongevityMEDLINEProbioticModels BiologicalCatalysisEpigenesis GeneticInorganic Chemistrylcsh:ChemistryMedicineHumansPhysical and Theoretical ChemistryMolecular Biologylcsh:QH301-705.5SpectroscopySettore MED/04 - Patologia GeneraleAged 80 and overClinical Trials as Topicbusiness.industryProbioticsOrganic ChemistryGeneral MedicineComputer Science ApplicationsDietChild mortalityEditorialn/alcsh:Biology (General)lcsh:QD1-999HealthbusinessHumanInternational journal of molecular sciences
researchProduct

Relative validity of a semi-quantitative food-frequency questionnaire in an elderly Mediterranean population of Spain

2010

The aim of the present study was to assess reproducibility and relative validity of a self-administered FFQ used in the PREDIMED Study, a clinical trial for primary prevention of CVD by Mediterranean diet in a population at high cardiovascular risk. The FFQ was administered twice (FFQ1 and FFQ2) to explore reproducibility at 1 year. Four 3 d dietary records (DR) were used as reference to explore validity; participants therefore recorded their food intake over 12 d in the course of 1 year. The degree of misclassification in the FFQ was also evaluated by a contingency table of quintiles comparing the information from the FFQ2 and the DR. A total of 158 men and women (aged 55– 80 years) were a…

GerontologyMaleMediterranean dietIntraclass correlationPopulationMedicine (miscellaneous)QüestionarisBioquímica i biotecnologiaDiet MediterraneanFFQDietary recordsDiet RecordsDiet SurveysValidityFood groupEnvironmental healthSurveys and QuestionnairesMedicineHumansMulticenter Studies as TopiceducationreproducibilityAgedRandomized Controlled Trials as TopicContingency tableBioquímica y tecnologíaeducation.field_of_studyNutrition and Dieteticsbusiness.industryfood and beveragesReproducibility of ResultsPREDIMED study0007-1145Middle AgedDiet SurveysDiet RecordsReproducibilityDietBiochemistry and technologyPREDIMED Study [Mediterranean population]SpainDietaFemalebusinessRelative validity
researchProduct